Cabaletta Bio Inc (NASDAQ:CABA) shares, rose in value, with the stock price down by -6.02% to the previous day’s close as strong demand from buyers drove the stock to $12.18.
Actively observing the price movement in the last trading, the stock closed the session at $12.96. Referring to stock’s 52-week performance, its high was $26.35, and the low was $7.69. On the whole, CABA has fluctuated by -28.18% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CABA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CABA currently trading nearly -24.17% and -36.24% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 21.74, while the 7-day volatility ratio is showing 6.92% which for the 30-day chart, stands at 6.42%. Furthermore, Cabaletta Bio Inc (CABA)’s beta value is 2.47, and its average true range (ATR) is 1.12.
A comparison of Cabaletta Bio Inc (CABA) with its peers suggests the former has fared considerably weaker in the market. CABA showed an intraday change of -6.02% in last session, and over the past year, it grew by 50.74%%.
Data on historical trading for Cabaletta Bio Inc (NASDAQ:CABA) indicates that the trading volumes over the past 3 months, they’ve averaged 970.15K. According to company’s latest data on outstanding shares, there are 47.82 million shares outstanding.
Nearly 18.86% of Cabaletta Bio Inc’s shares belong to company insiders and institutional investors own 88.31% of the company’s shares. The stock has fallen by -46.34% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CABA stock heading into the next quarter.
